Xylazine’s Rise in the Illicit Drug Supply Poses New Threat to Correctional Facilities

Correctional facilities have long faced the challenge of intercepting dangerous drugs smuggled through the mail. But a new threat is complicating detection efforts and endangering the safety of inmates and staff: Xylazine.

This powerful veterinary sedative, often mixed with fentanyl and other opioids, is increasingly showing up in contraband and mail-based smuggling attempts.

Because xylazine is not an opioid, its effects cannot be reversed by naloxone, making overdoses far more difficult to treat. The drug can also cause deep sedation, respiratory depression, and severe skin wounds, posing critical health risks in an already high-risk environment.

What is Xylazine and why is it so dangerous?
Xylazine is a sedative used by veterinarians to tranquilize large animals. When misused by humans, especially in combination with opioids, its impact is devastating. Unlike drugs like fentanyl, which can be quickly addressed with emergency overdose treatments, xylazine does not respond to opioid reversal agents, meaning medical emergencies can rapidly become fatal.

Some of the side effects include:

• Severe, difficult-to-treat sedation
• Dangerous respiratory depression
• Risk of flesh wounds and necrosis at injection sites

Its rising prevalence in mail-borne contraband is making it harder for correctional institutions to protect their populations.

Why is Xylazine showing up in the mail?
As drug traffickers grow more sophisticated, the mail system continues to be exploited. Incoming letters, legal documents, and other seemingly harmless materials are increasingly used to conceal dangerous substances, now including xylazine. Since it’s often mixed with other drugs, it may be unknowingly consumed by individuals who are not aware of what they’re ingesting, amplifying the risk of accidental overdose.